Session date: May 23, 2023
This session will focus on the prevalence, impact, and burden of comorbidities in chronic obstructive pulmonary disease, including a discussion of challenges and opportunities related to comorbidity screening in patients with COPD. This session also includes a more in-depth discussion of the more common COPD comorbidities, specifically depression, cardiovascular disease, and muscle dysfunction.
This session will focus on the prevalence, impact, and burden of comorbidities in chronic obstructive pulmonary disease, including a discussion of challenges and opportunities related to comorbidity screening in patients with COPD. This session also includes a more in-depth discussion of the more common COPD comorbidities, specifically depression, cardiovascular disease, and muscle dysfunction.
• Describe the burden and clinical implications of comorbidities in patients with COPD
• Integrate comorbidity screening into the current management of COPD patients
• Recognize research gaps in the management of COPD comorbidities
Phyliss DiLorenzo
Miguel Divo, MD, MPH
Victor Kim, MD, ATSF, FAASM
Jennifer Quint, FRCP, MSc, PhD
Harry Rossiter, PhD
Jessica Bon, MD, MS, ATSF
A Patient's Perspective
The Burden and Impact of Comorbidities in COPD
Anxiety and Depression in COPD: Prevalence, Risk Factors, and Clinical Implications
Cardiovascular Disease in COPD: Burden, Mechanisms, and Implications for Clinical Practice
Skeletal Muscle Dysfunction in COPD: Mechanisms and Implications
Comorbidity Screening in COPD: Challenges and Opportunities